Results 41 to 50 of about 15,050 (215)

Strongest Correlation Between Contrast Sensitivity and Morphological Characteristics in Bilateral nAMD

Frontiers in Medicine, 2021
In patients with neovascular age-related macular degeneration (nAMD) there is often an inconsistency between their subjective visual impairment and a still relatively preserved standard Early Treatment of Diabetic Retinopathy Study (ETDRS) best corrected
Laura Hoffmann, Petra Rossouw, Maria-Magdalena Guichard, K. Hatz   +3 more
semanticscholar   +1 more source

Ocular Therapeutics and Molecular Delivery Strategies for Neovascular Age-Related Macular Degeneration (nAMD)

International Journal of Molecular Sciences, 2021
Age-related macular degeneration (AMD) is the leading cause of vision loss in geriatric population. Intravitreal (IVT) injections are popular clinical option.
Aira Sarkar, V Junnuthula, Sathish Dyawanapelly   +2 more
semanticscholar   +1 more source

Analysis of Systemic and Serum Risk Factors in Patients with Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy

Ophthalmology and Therapy, 2023
Introduction It remains controversial whether polypoidal choroidal vasculopathy (PCV) represents a subtype of neovascular age-related macular degeneration (nAMD) or is a distinct disease entity.
Tianchang Tao, Hui Xu, Xiaoyun Ma, Yong Cheng, Xuan Shi, Yaoyao Sun, Mingwei Zhao, Lvzhen Huang, Xiaoxin Li   +8 more
doaj   +1 more source

Management of neovascular age-related macular degeneration: Taiwan expert consensus

Journal of the Formosan Medical Association, 2021
Neovascular age-related macular degeneration (nAMD) is a leading cause of irreversible vision loss. The present consensus provides suggestions on diagnosis, evaluation, treatment, and follow-up strategies for nAMD from a panel of 11 practicing ...
Ling Yeung, Yi-Ting Hsieh, Chang-Hao Yang, Lee-Jen Chen, Shih-Jen Chen, Cheng-Kuo Cheng, Shwu-Jiuan Sheu, Ching-Yao Tsai, Tsung-Tien Wu, Wei-Chi Wu, San-Ni Chen   +10 more
doaj   +1 more source

Real-life management of neovascular age-related macular degeneration (nAMD) in France: a nationwide observational study using retrospective claims data

Journal of Medical Economics, 2021
Aims Intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy is standard care for neovascular age-related macular degeneration (nAMD), but the recommended monthly injection regimen is burdensome.
J. Korobelnik, C. Delcourt, C. Creuzot-Garcher, A. Mélaine, Jules Chassetuillier, A. Lejeune, S. Bénard, L. Dupont-Benjamin   +7 more
semanticscholar   +1 more source

New Therapies of Neovascular AMD—Beyond Anti-VEGFs

Vision, 2018
Neovascular age-related macular degeneration (nAMD) is one of the leading causes of blindness among the aging population. The current treatment options for nAMD include intravitreal injections of anti-vascular endothelial growth factor (anti-VEGF ...
Praveen Yerramothu
doaj   +1 more source

Progression of age-related macular degeneration in eyes with abnormal fundus autofluorescence in a Japanese population: JFAM study report 3.

PLoS ONE, 2022
PurposeTo evaluate the progression of early age-related macular degeneration to neovascular age-related macular degeneration (nAMD), and identify the abnormal fundus autofluorescence (FAF) patterns and markers of choroidal neovascularization (CNV) in ...
Yuji Oshima, Ari Shinojima, Miki Sawa, Ryusaburo Mori, Tetsuju Sekiryu, Aki Kato, Chikako Hara, Masaaki Saito, Yukinori Sugano, Yoshio Hirano, Hitomi Asato, Mayumi Nakamura, Erika Kimura, Mitsuko Yuzawa, Tatsuro Ishibashi, Yuichiro Ogura, Tomohiro Iida, Fumi Gomi, Tsutomu Yasukawa   +18 more
doaj   +1 more source

Spotlight on Faricimab in the Treatment of Wet Age-Related Macular Degeneration: Design, Development and Place in Therapy

Drug Design, Development and Therapy, 2022
Archana A Nair, Avni P Finn, Paul Sternberg Jr Vanderbilt Eye Institute, Vanderbilt University Medical Center, Nashville, TN, USACorrespondence: Paul Sternberg Jr, Chair and G. W.
Nair AA, Finn AP, Sternberg P Jr
doaj  

Short-Term Treatment Outcomes of Brolucizumab in Patients with Neovascular Age-Related Macular Degeneration: A Multicentre Indian Real-World Evidence Study

Clinical Ophthalmology, 2023
Debdulal Chakraborty,1 Milan Thakkar,2 Ramesh Venkatesh,3 Sangeeta Roy,4 Maulik Bhavsar,5 Helene Karcher6 1Disha Eye Hospital, Kolkata, West Bengal, India; 2Dr.
Chakraborty D, Thakkar M, Venkatesh R, Roy S, Bhavsar M, Karcher H   +5 more
doaj  

Visual Outcomes of Anti-VEGF Treatment on Neovascular Age-Related Macular Degeneration: A Real-World Population-Based Cohort Study

Pharmaceuticals, 2023
Neovascular age-related macular degeneration (nAMD) leads to visual impairment if not treated promptly. Intravitreal anti-VEGF drugs have revolutionized nAMD treatment in the past two decades.
Ida Korva-Gurung, Anna-Maria Kubin, Pasi Ohtonen, Nina Hautala   +3 more
doaj   +1 more source